PINK1

Experiments suggest the Ser/Thr kinase domain faces outward toward the cytosol, indicating a possible point of interaction with parkin.

However, an over-expression of Drp1 could rescue subjects deficient in PINK1 or parkin, suggesting mitochondrial fission initiated by Drp1 recreates the same effects of the PINK1/parkin pathway.

Oxidative stress in mitochondria can produce potentially harmful compounds including improperly folded proteins or reactive oxygen species.

PINK1 has been shown to facilitate the creation of mitochondria-derived vesicles which can separate reactive oxygen species and shuttle them toward lysosomes for degradation.

[20] Parkinson's disease is often characterized by the degeneration of dopaminergic neurons and associated with the build-up of improperly folded proteins and Lewy bodies.

[21] Specifically, mutations in the serine/threonine kinase domain have been found in a number of Parkinson's patients where PINK1 fails to protect against stress-induced mitochondrial dysfunction and apoptosis.

The first report appeared in 2013 when Kevan Shokat and his team from UCSF identified a nucleobase called kinetin as an activator of PINK1.

Damaged mitochondria is being recognized by PINK1. PINK1 builds up on the outer membrane of the mitochondria and recruits parkin. The PINK1/parkin pathway then designates the mitochondria for degradation by lysosomes.
Healthy mitochondria can import PINK1 where it is subsequently cleaved by PARL . This prevents any buildup of PINK1 and parkin is not recruited to the mitochondria.